¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ½ÃÀå : ±Ô¸ð ¹× ¿¹Ãø - Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2023-2030³â)
Global Brain Monitoring Market Size Study & Forecast, by Product Type, by Application, by End User, and Regional Analysis, 2023-2030
»óǰÄÚµå : 1441363
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2024³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,786,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,569,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ³ú ¸ð´ÏÅ͸µ ½ÃÀå ±Ô¸ð´Â 2022³â ¾à 60¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇßÀ¸¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â µ¿¾È 6.35% ÀÌ»óÀÇ °Ç°­ÇÑ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³ú ¸ð´ÏÅ͸µ ÀåÄ¡´Â ³úÀÇ ±¸Á¶¿Í ±â´ÉÀ» °Ë»çÇÏ¿© ½Å°æÇÐÀû »óŸ¦ ¸ð´ÏÅ͸µÇϰí Áø´ÜÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù.

³ú ±â´ÉÀ» ÃßÀûÇϱâ À§ÇØ ³úÆÄ ÀåÄ¡, µÎ°³³»¾Ð ¸ð´ÏÅÍ, ³ú ÀÚ±â°ø¸í¿µ»ó µî ´Ù¾çÇÑ ÀåÄ¡°¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡µéÀº ³úÀÇ ½Å°æ Ȱµ¿°ú Àü±âÀû Ȱµ¿À» ¸ð´ÏÅ͸µÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ³ú ¸ð´ÏÅ͸µÀº ´Ù¾çÇÑ ±â¼úÀ» ÅëÇØ ³úÀÇ È°µ¿À» Áö¼ÓÀûÀ¸·Î °üÂûÇÏ°í ±â·ÏÇÏ¿© Àå¾Ö Áø´Ü, Ä¡·á Áöħ, ¼ö¼ú ¹× ÁßÁõ Ä¡·á Áß ³úÀÇ °Ç°­ »óŸ¦ Æò°¡ÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ¼öÁýµÈ µ¥ÀÌÅÍ´Â ³ú ±â´ÉÀ» ÀÌÇØÇϰí ÀÇ·á °³ÀÔÀ» À§ÇÑ Á¤º¸¸¦ Á¦°øÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ³ú ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ¼ºÀåÀº ½Å°æ ÅðÇ༺ Áúȯ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¿Ü»ó¼º ³ú¼Õ»ó Áõ°¡, ³ú ¸ð´ÏÅ͸µ µµ±¸ÀÇ Ä¡·á ¿ëµµ È®´ë, ÀÓ»ó½ÃÇè¿¡¼­ ³ú ¸ð´ÏÅ͸µ »ç¿ëÀÇ ±ÞÁõ¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Alzheimer Disease International Organization(Alzheimer Disease International Organization)ÀÇ Á¶»ç¿¡ µû¸£¸é, 2020³â Àü ¼¼°è Ä¡¸Å ȯÀÚ ¼ö´Â ¾à 5¾ï 5õ¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 5,500¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ¼ýÀÚ´Â 2030³â±îÁö 7,800¸¸ ¸íÀ¸·Î Áõ°¡Çϰí, 2050³â¿¡´Â 1¾ï 3,900¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ ÀÚÆóÁõ°ú °°Àº ½Å°æÁúȯµµ Àü ¼¼°èÀûÀ¸·Î ¸¸¿¬ÇØ ÀÖÀ¸¸ç, ¼¼°èº¸°Ç±â±¸(WHO)´Â Àü ¼¼°è ¾î¸°ÀÌ 100¸í Áß 1¸íÀÌ ÀÚÆóÁõÀÎ °ÍÀ¸·Î ÃßÁ¤Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ³ú ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ³ú ¸ð´ÏÅ͸µ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¶ÇÇÑ, Á¦Ç° Ãâ½Ã, ÇÕº´, Àμö µîÀÇ Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, NeuroWave Systems´Â ÀÓ»ó ȯ°æ¿¡¼­ ¸¶Ãë ¹× ÁøÁ¤ÀÇ ÀûÀý¼ºÀ» Æò°¡Çϱâ À§ÇØ ¼³°èµÈ NeuroSense NS-901 ¸ð´ÏÅÍ·Î FDA ½ÂÀÎÀ» ȹµæÇß½À´Ï´Ù. ¶ÇÇÑ, ºê·¹ÀλçÀ̾ðƼÇÈÀº ÀÏ»óÀûÀÎ ÀÓ»ó ¹× ¿¬±¸ ÇöÀå¿¡¼­ ½Å¼ÓÇÑ ³úÆÄ ÃøÁ¤À» °¡´ÉÇÏ°Ô Çϴ ÷´Ü ³úÆÄ Àü±Ø ¾î·¹ÀÌÀÎ Next-Gen NeuroCap EEG Headset¿¡ ´ëÇÑ FDA ½ÂÀÎÀ» ȹµæÇß½À´Ï´Ù. ÀÌ¿Í °°ÀÌ ¾Õ¼­ ¾ð±ÞÇÑ ¿äÀεéÀº ¿¹Ãø ±â°£ µ¿¾È ³ú ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºñħ½ÀÀû, Àúħ½ÀÀû ±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ½ÅÈï±¹ÀÇ ÀÇ·á ºÐ¾ß È®´ë´Â ¿¹Ãø ±â°£ µ¿¾È ´Ù¾çÇÑ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÇÏÁö¸¸, 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ±â±â ½ÂÀο¡ ´ëÇÑ ±î´Ù·Î¿î ±ÔÁ¦¿Í ±â±â Ãë±ÞÀ» À§ÇÑ ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·Àº ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¼¼°è ³ú ¸ð´ÏÅ͸µ ½ÃÀå Á¶»ç ´ë»ó ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« µîÀÔ´Ï´Ù. ºÏ¹Ì´Â Àß ±¸ÃàµÈ ÀÇ·á ÀÎÇÁ¶ó, ³ú ¸ð´ÏÅ͸µ Á¦Ç° ÀÓ»ó½ÃÇèÀÇ ±ÞÁõ, ÀÇ·áºñ »óȯÀÇ ¿ëÀ̼º µîÀ¸·Î ÀÎÇØ 2022³â ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ª ½ÃÀåÀº À¯¸®ÇÑ »óȯ Á¤Ã¥°ú Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. µû¶ó¼­ ¸ð¹ÙÀÏ ³úÆÄ ±â±â, ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× °æ°í ½Ã½ºÅÛÀÇ °³Ã´Àº ÀÌ Áö¿ª ½ÃÀå È®´ë¿¡ ±â¿©ÇÏ´Â Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 5¿ù Philips´Â ÃֽŠMR 7700 3.0T MR ½Ã½ºÅÛÀ¸·Î FDA 510(k) ½ÂÀÎÀ» ȹµæÇÏ¿© ¹æ»ç¼±°ú Àü¹®Àǰ¡ ´Ù¾çÇÑ ÇØºÎÇÐÀû ºÎÀ§¿¡ °ÉÃÄ 6°¡Áö ÀÓ»ó °ü·Ã ÇÙÀ» ÃÔ¿µÇÒ ¼ö ÀÖ´Â ±ÇÇÑÀ» ºÎ¿©Çß½À´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Å°æ ÁúȯÀÇ ±ÞÁõ, ³ëÀÎ Àα¸ Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡·Î ÀÎÇØ ÀÌ Áö¿ª ½ÃÀå ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³âµ¿¾È ´Ù¾çÇÑ ºÎ¹®¿Í ±¹°¡º° ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³âµ¿¾È ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ, ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú µµÀü °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷µéÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

Á¦3Àå ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ½ÃÀå ¿ªÇÐ

Á¦4Àå ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ½ÃÀå »ê¾÷ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦6Àå ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ½ÃÀå : ¿ëµµº°

Á¦7Àå ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦8Àå ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ½ÃÀå : Áö¿ªº° ºÐ¼®

Á¦9Àå °æÀï Á¤º¸

Á¦10Àå Á¶»ç °úÁ¤

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Brain Monitoring Market is valued at approximately USD 6.01 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.35% during the forecast period 2023-2030. Brain monitoring devices are used for monitoring and diagnosing neurological conditions by examining the structure and function of the brain. Various devices, including electroencephalography devices, intracranial pressure monitors, and magnetoencephalography, are employed to track brain functions. These devices also aid in monitoring neural and electrical activity in the brain. Brain monitoring involves continuously observing and recording brain activity using various techniques to help diagnose disorders, guide treatments, and assess brain health during surgeries or critical care. The gathered data aids in understanding brain function and informing medical interventions. The growth of the Brain Monitoring Market is driven by the growing awareness of neurodegenerative diseases, a rise in traumatic brain injuries, the widening therapeutic applications of brain monitoring tools, and the surging use of brain monitoring in clinical trials.

Additionally, the increasing incidence of neurological disorders is directly associated with the growth of the Brain Monitoring Market across the globe. As per the research from the Alzheimer Disease International Organization, the number of individuals worldwide affected by dementia was around 55 million in 2020. This number is projected to increase to 78 million by 2030 and reach 139 million by 2050. Also, neurological diseases like autism are widespread globally, with the World Health Organization (WHO) estimating that one in 100 children worldwide has autism. This escalating prevalence of brain disorders is likely to positively impact the Brain Monitoring Market. Furthermore, strategic initiatives such as product launches, mergers, and acquisitions are anticipated to contribute to market growth. For example, NeuroWave Systems Inc. received FDA clearance for its NeuroSENSE NS-901 Monitor, designed for assessing anesthesia and sedation adequacy in clinical settings. Additionally, Brain Scientific obtained FDA clearance for the Next-Gen NeuroCap EEG Headset, an advanced electroencephalography (EEG) electrode array facilitating rapid EEGs in routine clinical and research settings. Thus, these aforementioned factors are propelling the growth of the Brain Monitoring Market over the estimated period. Moreover, the rising demand for non-invasive and minimally invasive devices, as well as the expanding healthcare sector in emerging economies present various lucrative opportunities over the forecast years. However, the unavailability of skilled professionals to handle devices and the stringent regulations for device approval are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Brain Monitoring Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the well-established healthcare infrastructure, a surge in clinical trials for brain monitoring products, and the accessibility of medical reimbursement. Furthermore, the market in the region has witnessed growth due to favorable reimbursement policies and ongoing technological advancements. Accordingly, the development of mobile EEG machines, real-time monitoring, and alert systems has played a significant role in contributing to the regional market expansion. For instance, in May 2022, Philips received FDA 510(k) clearance for its latest MR 7700 3.0T MR system, empowering radiologists to capture six distinct clinically relevant nuclei across various anatomies. Whereas, Asia Pacific is expected to grow at the fastest CAGR over the forecast years. The surge in neurological diseases, growing aging population, and increase in healthcare expenditure are significantly propelling the market demand across the region.

Major market players included in this report are:

Recent Developments in the Market:

Global Brain Monitoring Market Report Scope:

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

By Application:

By End User:

By Region:

Table of Contents

Chapter 1. Executive Summary

Chapter 2. Global Brain Monitoring Market Definition and Scope

Chapter 3. Global Brain Monitoring Market Dynamics

Chapter 4. Global Brain Monitoring Market Industry Analysis

Chapter 5. Global Brain Monitoring Market, by Product Type

Chapter 6. Global Brain Monitoring Market, by Application

Chapter 7. Global Brain Monitoring Market, by End User

Chapter 8. Global Brain Monitoring Market, Regional Analysis

Chapter 9. Competitive Intelligence

Chapter 10. Research Process

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â